Spain· ES:1181308001
VYXEOS LIPOSOMAL 44 MG/100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
A medicinal product containing daunorubicina + citarabina, registered in Spain by Jazz Pharmaceuticals Ireland Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- daunorubicina + citarabina
- Manufacturer
- Jazz Pharmaceuticals Ireland Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Daunorubicina + citarabina in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandVyxeos liposomal 44 mg/100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionsdispersionJazz Pharmaceuticals Switzerland GmbH
- CzechiaVYXEOS LIPOSOMALJazz Pharmaceuticals Ireland Ltd, Dublin
- FinlandVyxeos liposomalOrifarm Oy
- IrelandVyxeos liposomal 44 mg/100 mg powder for concentrate for solution for infusionJazz Pharmaceuticals Ireland Limited
- IcelandVyxeos liposomalJazz Pharmaceuticals Ireland Ltd
- NetherlandsVyxeos liposomal 44 mg/100 mg poeder voor concentraat voor oplossing voor infusieJazz Pharmaceuticals Ireland Limited
- NorwayVyxeos liposomalJazz Pharmaceuticals Ireland Limited
- PolandVyxeos liposomalJazz Pharmaceuticals Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyxeos Liposomal
- Liechtenstein · Vyxeos Liposomal
- Norway · Vyxeos Liposomal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6f8b61e-3560-4045-ad7e-b626b8c3231f GET /v1/drugs/d6f8b61e-3560-4045-ad7e-b626b8c3231f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1545174000000}",
"nregistro": "1181308001",
"substance": "daunorubicina + citarabina"
}See everything about daunorubicina + citarabina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.